eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	OPHTHALIX, INC
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A clinical-stage biopharmaceutical company focused on developing therapeutic products for the treatment of ophthalmic disorders.
Lead Underwriter	Maxim Group, LLC
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A